Drug Development Insurance Coverage and Processing Webinar 
Pharmacy Times
JULY 22, 2025
Personalized drug selection can lead to faster symptom control, fewer hospitalizations, and improved adherence—all of which contribute to better outcomes and a more streamlined care process. Real-World Evidence, Emerging Therapies, and Demonstrating Value Technological advances are accelerating this progress.
Pharmaceutical Technology
JULY 9, 2025
JCR has also developed a proprietary blood-brain barrier-penetrating technology, J-Brain Cargo, to deliver biotherapeutics into the central nervous system. IZCARGO is the first drug developed with this technology and approved in Japan for treating a lysosomal storage disorder.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JULY 14, 2025
Robert Barrie July 14, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Broader label coverages for Pfizer and Moderna’s vaccines mean they have made in-roads into GSK’s RSV dominant market share. MAXSHOT.PL via Shutterstock. Give your business an edge with our leading industry insights.
Pharmaceutical Technology
JULY 14, 2025
The company is confident that these concerns, which pertain to facilities and processes rather than product quality, can be promptly addressed. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Efforts are underway to work with the FDA to resolve them.
Pharmaceutical Technology
JULY 30, 2025
The future of DMD drug development now hinges on who steps into the role and how the FDA navigates this high-profile therapeutic area.” ” The public playout of DMD treatment developers with the FDA is not only impacting biopharma share prices but also raising concerns about the agency’s internal operations.
Pharmaceutical Technology
JULY 17, 2025
Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content. Give your business an edge with our leading industry insights.
Expert insights. Personalized for you.
Let's personalize your content